Maxim's Apoptosis Inhibitor Protects Against Kidney Ischemia/Reperfusion Injury in Preclinical Study; Results Presented at the American Transplant Congress Meeting.
Linked as:
Extract
Maxim's Apoptosis Inhibitor Protects Against Kidney Ischemia/Reperfusion Injury in Preclinical Study; Results Presented at the American Transplant Congress Meeting.
Business Editors & Health/Medical Writers
BIOWIRE2K SAN DIEGO--(BW HealthWire)--May 6, 2002 Maxim Pharmaceuticals Inc. (Nasdaq NM: MAXM, SSE: MAXM) announced the results of research suggesting that the company's investigational apoptosis inhibitor MX1122 reduced kidney ischemia/reperfusion injury in a preclin...See the full content of this document
Sponsored links
